Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2011 Results
Date:5/5/2011

pared to $12.4 million for the same period in 2010.  First quarter 2011 revenues included $0.9 million related to Fanapt® royalties received from Novartis as compared to $2.1 million for the first quarter of 2010.  The higher first quarter 2010 royalty revenue was the result of initial wholesaler stocking at launch.   First quarter 2010 revenues also included one-time product sales to Novartis of $3.7 million.  Total operating expenses for the first quarter of 2011 were $7.5 million, compared to $6.3 million for the first quarter of 2010.  The primary driver of the higher expenses in the first quarter of 2011 was the ongoing support of the tasimelteon N24HSWD clinical studies.

Net income was $0.1 million for the first quarter of 2011, compared to $0.5 million for the first quarter of 2010.  Basic and diluted earnings per share for the first quarter of 2011 were $0.00, compared to $0.02 per share for the first quarter of 2010.

First Quarter 2011 Key Financial Figures (1)Three Months EndedMarch 31December 31(in thousands, except per share amounts)

20112010  Change ($)Change (%)Total revenues

$
7,501$
7,752$
(251)-3%Research & development  expenses

4,2673,82244512%General & administrative expenses

2,8582,762963%Non-cash stock-based compensation (2)

1,6041,33526920%Net income before tax provision

142933(791)-85%Tax provision (benefit)

6(1,266)1,272100%Net income

1362,200(2,064)-94%Diluted net income per share

$
.00$
.08$
(0.08)-100%Select Cash Flow Data (1)(In thousands)

Three Months EndedMarch 31March 3120112010Net cash provided by (used in)Operating activities

(3,264)(4,826)Investing activities

13,225(32,457)Financing activities

-1,933Net change in cash and cash equivalents

$
9,961$
(35,350)Select Balance Sheet Data (1)March 31December 31March 31(in thous
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
2. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
3. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
4. Vanda Pharmaceuticals Reports First Quarter 2009 Results
5. Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
6. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
7. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
8. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Results
9. Vanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010
10. Vanda Pharmaceuticals to Announce Fourth Quarter 2010 Financial Results on February 10, 2011
11. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014  Health Enhancement Products, Inc. (OTCQB: HEPI), a ... bioactive compounds and metabolic processes, is pleased to announce the ... directors. Ms. Nola E. Masterson , a ... board effective September 17, 2014. "We,re very ... our board," states Andrew Dahl , President and CEO. ...
(Date:9/18/2014)... -- Research and Markets has announced the ... Industry Report, 2014-2017" report to their offering. ... can differentiate into specialized cells and can divide (through ... can be applied to treatment of cardiovascular diseases, leukemia ... damage or lesion of liver, kidney and other parenchymal ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Leatherwood ... FM-4910 listed material, to stay competitive in the ... These high-performance materials ultimately impact product quality and ... and owner. , Established in 1980 in Lewisville, ... as many fabricators have left the business. Much ...
(Date:9/18/2014)... , Sept. 18, 2014 /PRNewswire/ - Oncothyreon Inc. ... of previously announced concurrent but separate underwritten offerings of ... to the public of $2.00 per share, for expected ... its Series A Convertible Preferred Stock at a price ... gross proceeds of $20 million. Each share of Series ...
Breaking Biology Technology:Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3
... Inc.,(NYSE: SNN , LSE: SN) Orthopaedic Reconstruction ... instrumentation for use in total,knee replacement surgery. The VISIONAIRE ... x-rays to create custom surgical instrumentation for,use with the ... , By using instruments designed ...
... EAST LONGMEADOW, Mass., Feb. 23 Texcel Medical, ... development and contract manufacturing company, has announced ... CEO.Smith will oversee all functions at Texcel ... by providing the manufacturing infrastructure and expertise they ...
... Affairs Company LLC,(TMAC(R)), the leading provider of outsourced ... expansion of its medical,communications division. , ... demand for clinician-staffed,project-based medical information and medical meeting ... its Medical Communications division to,better meet these needs. ...
Cached Biology Technology:Smith & Nephew Launches VISIONAIRE(TM) Patient Matched Technology for Total Knee Replacement 2Smith & Nephew Launches VISIONAIRE(TM) Patient Matched Technology for Total Knee Replacement 3Texcel Medical Appoints Barry Smith as President, CEO 2The Medical Affairs Company Expands Its Medical Communications Division 2
(Date:9/18/2014)... cycles of carbon and nitrogen comprise all spheres ... environmental systems have caused imbalances and perturbations that ... (GHGs). Increased GHGs result in climate changes which ... oceans and the atmosphere. Understanding these feedback mechanisms ... of environmental science during the past three decades. ...
(Date:9/18/2014)... camouflage: you don,t just blend in, the background shows ... as you might think. Kathryn Feller, from the University ... life stages of many marine species are transparent. However, ... creatures cannot make transparent. Feller explains that the animals ... unit with an opaque pigment to prevent light leaking ...
(Date:9/17/2014)... of the Santa Ana Wildfire Threat Index a ... the powerful, hot, dry Santa Ana wind, which can ... introduced Sept. 17 by the U.S. Forest Service, in ... , The index includes four classification levels ranging from ... fire agencies and other emergency responders, the media and ...
Breaking Biology News(10 mins):Greenhouse gas research enters a new era 2Transparent larvae hide opaque eyes behind reflections 2UCLA scientists play key role in developing new Santa Ana Wildfire Threat Index 2
... a plant genetics and developmental biology expert at the ... of 15 five-year, $5 million grants for fundamental plant ... the Howard Hughes Medical Institute (HHMI) and the Gordon ... W. Beadle Professor of Biology at Caltech, is an ...
... the Bourns College of Engineering at the University of California, ... EPA to develop a system could cut electricity bills up ... attic to operate a clothes dryer. The students are ... a 30-home zero net energy, urban agriculture focused community planned ...
... RIDGE, Tenn., June 15, 2011 A first of ... Department of Energy,s Oak Ridge National Laboratory is providing ... biofuels. , Lignin, a major component of plant cell ... the production of cellulosic ethanol. The exact shape and ...
Cached Biology News:Caltech scientist awarded $5 million grant for plant research 2Turning hot air into energy savings 2Turning hot air into energy savings 3ORNL neutrons, simulations reveal details of bioenergy barrier 2
Rabbit polyclonal to hnRNP-U...
... DNA Ligase catalyzes the formation of a ... termini in nicked duplex DNA molecules or ... a complementary strand at 45 - 65?. ... at much higher temperatures than conventional DNA ...
RABBIT ANTI RHEB (IN) Immunogen: A 15 amino acid peptide located in the central region of human Rheb....
Rabbit polyclonal antibody to Neuromedin U Receptor 1 (GPR66)...
Biology Products: